Medsafe Logo
Hide menus
Show menus

Publications

Published: 20 March 2017

Primodos

The Ministry of Health and Medsafe are aware of public interest around the product Primodos.

Any indications that a medicine may have caused serious adverse effects are treated extremely seriously by both the Ministry of Health and Medsafe.

As the current reports relate to a period more than 50 years ago, the Ministry has been urgently working through its archival files to establish the specifics of use for Primodos in this country.

Today, we have established that

We have also searched for any files which may be held by the Centre for Adverse Reactions Monitoring (CARM) in Dunedin.

http://www.medsafe.govt.nz/profs/PUarticles/ADRreport.htm

CARM has been operating since 1965 so if adverse reports relating to a product such as Primodos had been received, we would expect them to have been held there.

We'll continue to provide updated additional information as it becomes available and would advise any members of the public who may have specific concerns about Primodos to contact Healthline - 0800 611 116 - or email the Ministry on info@health.govt.nz

Medsafe has a memorandum of understanding with the Medicines & Healthcare products Regulatory Agency (MHRA) in the United Kingdom and will receive any relevant information from its review as it becomes available.

BACKGROUND INFORMATION

Primodos was a hormone based preparation containing norethisterone and ethinylestradiol.

ENDS

0 1 2 4 5 6 7 9 [ /